Calibr Researcher Screens for COVID-19 Antiviral Drugs (IMAGE)

Scripps Research Institute

Calibr Researcher Screens for COVID-19 Antiviral Drugs

Caption

A researcher at Calibr, the drug discovery division of Scripps Research, working in the high-throughput screening facility used to identify potential COVID-19 therapies.

Credit

Scripps Research

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.